Is there an infective aetiology to atherosclerosis?

Drugs and Aging

Volumn 13, Issue 1, 1998, Pages 1-7

  Gupta, Sandeep ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY PREVENTION; SEROEPIDEMIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ARTERIOSCLEROSIS; CHLAMYDIACEAE INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0031927790     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199813010-00001     Document Type: Article

References (57)

1. Sans S, Kesteloot H, Kromhout D, et al. The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J 1997; 18: 123-48
2. Singh RB, Mori H, Chen J, et al. Recommendations for the prevention of coronary artery disease in Asians: a scientific statement of the International College of Nutrition. J Cardiovasc Risk 1996; 3: 489-94
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9
4. Azar RR, Waters DD. The inflammatory etiology of unstable angina. Am Heart J 1996; 132: 1101-6
5. Hansson GK. Immune mechanisms in atherosclerosis. Atherosclerosis 1989; 9: 567-8
6. Steinberg D, Parthasarathy S, Carew T, et al. Modifications of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320: 915-24
7. Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med 1978; 148: 335-40
8. Fabricant CG, Fabricant J, Minick CR, et al. Herpesvirus-induced atherosclerosis in chickens. Fed Proc 1983; 42: 2467-9
9. Havlik RJ, Blackwelder WC, Kaslow R, et al. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages: the Framingham Heart Study. Arteriosclerosis 1989; 9: 877-80
10. Melnick JL, Petrie BL, Dreesman GR, et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; II: 644-7
11. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-30
12. McDonald K, Rector TS, Braunlin EA, et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359-62
13. Kol A, Sperti G, Shani J, et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995; 91: 1910-3
14. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-6
15. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-9
16. Martin-de-Argila C, Boixeda D, Canton R, et al. High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet 1995; 346: 310
17. Murray LJ, Bamford KB, O'Reilly DP, et al. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74: 497-501
18. Whincup PH, Mendall MA, Perry IJ, et al. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1996; 75: 568-72
19. Wald NJ, Law MR, Morris JK, et al. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 1997; 315: 1199-201
20. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4
21. Parente F, Maconi G, Imbesi V, et al. Helicobacter pylori infection and coagulation in healthy people. BMJ 1997; 314: 1318-9
22. Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34: 2766-9
23. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779-82
24. Jousilahti P, Vartianinen E, Tacomilekhot T, et al. Symptoms of chronic bronchitis and risk of coronary disease. Lancet 1996; 348: 567-72
25. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic-coronary heart disease and acute myocardial infarction. Lancet 1988; II: 983-6
26. Wang SP, Grayston JT. Microimmunofluorescence serology in Chlamydia trachomatis. In: de la Maza LM, editor. The 1983 International Symposium on Medical Virology. New York: Elsevier Science, 1984: 87-118
27. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. BMJ 1997; 314: 1778-9
28. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Atr Med J 1992; 82: 158-61
29. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-9
30. Kuo CC, Gown AM, Benditt EP, et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13: 1501-4
31. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-8
32. Davidson M, Kuo CC, Middaugh JP, et al. Chlamydia pneumoniae (TWAR) in Alaska natives with coronary atheroma [abstract]. Clin Infect Dis 1995; 21: 726
33. Tuazon CU, Varghese PJ, Gaydos CA, et al. Demonstration of Chlamydia pneumoniae in coronary atheroma specimens from young patients with normal cholesterol from the Southern part of India [abstract]. Clin Infect Dis 1995; 21: 728
34. Kuo CC, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A 1995; 92: 6911-4
35. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-400
36. Ong G, Thomas BJ, Mansfield AO, et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Path 1996; 49: 101-6
37. Ong G, Thomas BJ, Mansfield AO, et al. Chlamydia pneumoniae in vascular tissue. In: Stary A, editor. Proceedings of the 3rd Meeting of the European Society of Chlamydia Research; 1996 Sep 11-14: Vienna: 222
38. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27: 1555-61
39. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996; 173: 957-62
40. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Intern Med 1996; 125: 979-82
41. Jackson LA, Campbell LA, Kuo CC, et al. Isolation of Chlamydia pneumoniae from a carotid atherosclerotic plaque specimen. J Infect Dis 1997; 176: 292-5
42. Juvonen J, Juvonen T, Laurila A, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997; 25: 499-505
43. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64: 1614-20
44. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microbiol Pathog 1996; 21: 215-21
45. Mendall MA, Carrington D, Strachan DP, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121-8
46. Leatham EW, Bath PM, Tooze JA, et al. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-3
47. Juvonen J, Laurila A, Juvonen T, et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1991; 29: 1054-9
48. Moazed TC, Kuo CC, Patton DL, et al. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996; 148: 667-78
49. Fong IW, Chiu B, Viira E, et al. Rabbit models for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35: 48-52
50. Laitinen K, Laurila A, Pyhälä L, et al. Chlamydia pneumoniae induces inflammatory changes in the aortas of rabbits. Infect Immun 1997; 65: 4832-5
51. Gupta S, Leatham EW, Carrington D, et al. The effect of azithromycin in post myocardial infarction patients with elevated Chlamydia pneumoniae antibody titres [abstract]. J Am Coll Cardiol 1997; 755: 209
52. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-7
53. Gurfinkel E, Bozovich G, Darcoca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404-7
54. Black PN. Anti-inflammatory effects of macrolide antibiotics. Eur Respir J 1997; 10: 971-2
55. Moxon ER. Microbes, molecules and man: the Mitchell Lecture 1992. J R Coll Physicians Lond 1993; 27: 169-74
56. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633-6
57. Gupta S, Kaski JC, Camm AJ. Antibiotic therapy in coronary heart disease: hype versus hope. Br J Cardiol 1998; 5: 65-6